The role of diminished β cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus

Journal of the Medical Association of Thailand

Volumn 84, Issue 12, 2001, Pages 1754-1762

  Rattarasarn, Chatchalit ^a   Leelawattana, Rattana ^a   Setasuban, Worawong ^a   Thamprasit, Atchara ^a   Soonthornpun, Supamai ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Glucagon Test; Insulin Resistance; Insulin Tolerance Test; Oral Glucose Tolerance Test; Sulfonylurea Failure; Type 2 Diabetes Mellitus

Indexed keywords

C PEPTIDE; GLIBENCLAMIDE; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; MONOCOMPONENT INSULIN; SULFONYLUREA;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; DIET; DISEASE DURATION; FEMALE; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; TREATMENT FAILURE;

AGED; DIABETES MELLITUS, TYPE 2; DRUG TOLERANCE; FEMALE; HUMANS; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; SULFONYLUREA COMPOUNDS;

EID: 0035561214     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992; 15: 318-68.
2. U.K. Prospective Diabetes Study Group. U.K. prospective diabetes study 16 : Overview of 6 years therapy of type II diabetes : A progressive disease. Diabetes 1995; 44: 1249-58.
3. Leahy JL, Bonner-Weir S, Weir GC. β-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 1992; 15: 442-55.
4. Groop L, Schalin C, Franssila-Kallunki A, Widen E, Ekstrand A, Eriksson J. Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy. Am J Med 1989; 87: 183-90.
5. Park S-W, Ihm S-H, Yoo HJ, Park JY, Lee K-U. Differential effects of ambient blood glucose level and degree of obesity on basal serum c-peptide level and the c-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1997; 37: 165-71.